Prothena (FRA:0PT) Other Long Term Assets : €45.8 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Prothena Other Long Term Assets?

Prothena's other long-term assets for the quarter that ended in Dec. 2024 was €45.8 Mil.

Prothena's quarterly other long-term assets increased from Jun. 2024 (€40.9 Mil) to Sep. 2024 (€41.1 Mil) and increased from Sep. 2024 (€41.1 Mil) to Dec. 2024 (€45.8 Mil).

Prothena's annual other long-term assets increased from Dec. 2022 (€29.2 Mil) to Dec. 2023 (€37.7 Mil) and increased from Dec. 2023 (€37.7 Mil) to Dec. 2024 (€45.8 Mil).

Prothena Other Long Term Assets Historical Data

The historical data trend for Prothena's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prothena Other Long Term Assets Chart

Prothena Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

10.96

9.22

29.20

37.69

45.75

Prothena Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															37.69	37.85	40.91	41.10	45.75

Prothena Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Prothena Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prothena Corp PLC (FRA:0PT) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

PRTA:USA 0Y3M:UK

Address

77 Sir John Rogerson’s Quay, Block C, Grand Canal Docklands, Dublin 2, IRL, D02 VK60

Website

https://www.prothena.com

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Prothena Headlines

No Headlines